3D BioPrinting R&D Driving Bio/FoodTech Disruption

David Keller
3 min readDec 19, 2022


Bioprinting is a rapidly evolving field that uses 3D printing technology to create living tissue and organs for medical and agricultural applications. This technology has the potential to revolutionize the way we approach tissue engineering, drug development, and food production. Given its wide array of applications to different fields, I wanted to dedicate some time to discussing its dynamics, trajectory, and some major players driving innovation.

Source: https://www.grandviewresearch.com/industry-analysis/3d-bioprinting-market

But first for its real world applications. I remember some of the 1st-gen 3D printers in college during the 2000s and was blown away by the potential. Fast forward 15 years, and the field has developed tremendously in directions I for one never even contemplated. One of the leading use cases for 3D bioprinting is the creation of advanced therapeutics for the treatment of diseases. By using 3D bioprinting, researchers can create functional tissues and organs that can be used to test the efficacy and safety of new drugs. For example, organs such as livers and kidneys can be bioprinted and used to test the effects of new drugs on these organs. This can help to reduce the need for animal testing and accelerate the development of new treatments.

Source: https://upload.wikimedia.org/wikipedia/commons/8/83/Advs2797-fig-0001-m.jpg

Another leading use case for 3D bioprinting is cultivated agriculture, which involves using bioprinting technology to grow plant-based proteins for food production. By using 3D bioprinting, it is possible to create plant-based proteins that have the same texture and taste as meat, without the need for animal farming. This can help to reduce the environmental impact of food production and meet the growing demand for plant-based proteins.

Source: https://www.amsbio.com/wp//wp-content/uploads/2021/10/How-is-Cultured-Meat-Made-01-resized-.png

There are several companies that are disrupting the market with their innovations in 3D bioprinting technology. One such company is Steakholder Foods, which is using 3D bioprinting to create cellular agriculture alternative proteins that mimic the texture and taste of real meat/seafood. The company is using a proprietary 3D bioprinting process to create create full cuts of meat — think racks of ribs and prime roast — with customizable weights, fat/muscle content, and even thickness. Just last week, Steakholder Foods the deveopment of a temperature-controlled print bed for its industrial-scale printer, representing yet another step forward in 3D bioprinter R&D.

Another key player in the 3D bioprinting market is Modern Meadow, which is using bioprinting technology to create cultivated leather and meat. The company is using 3D bioprinting to create leather that is environmentally friendly and cruelty-free, while also working on the development of cultivated meat products. As cellular agriculture continues to gain momentum as a promising solution for global food security, watchers can expect investment capital to keep flowing into 3D bioprinter development.

Finally, Advanced Solutions is another company that is disrupting the 3D bioprinting market with its innovative technology. The company is focused on developing 3D bioprinting solutions for the medical and research sectors, including the development of 3D bioprinted tissues and organs for drug testing and research. Advanced Solutions’ 3D bioprinting technology has the potential to revolutionize the way we approach tissue engineering and drug development, by reducing the need for animal testing and accelerating the development of new treatments.

In conclusion, 3D bioprinting is a rapidly evolving field with a wide range of potential applications. From advanced therapeutics to cultivated agriculture, this technology has the potential to revolutionize the way we approach tissue engineering, drug development, and food production. With key disruptors such as Steakholder Foods, Modern Meadow, and Advanced Solutions leading the way, the future looks bright for 3D bioprinting technology.



David Keller

Market analyst into the intersection of technology, finance, society, politics, and macro-econ. Straddles the NY-TLV axis. Fortis Fortuna Adiuvat.